
Preference for Finished Medicinal Products: How the Bundestag Sacrifices Cannabis Patients — and Why Hardly Anyone Saves
The Bundestag has decided on a priority regulation for cannabis finished medicinal products in the GKV savings law. Flowers and pharmacy-made preparations are relegated to the end of the prescription chain. The hemp association calls it "scandalous", the Pharmazeutische Zeitung a "foreign body in the savings law". An analysis — critical, from a patient's perspective, with figures.
Read more →













